Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate Potential
Circulation: Genomic and Precision Medicine · 2024
DOI: 10.1161/circgen.123.004415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024. Verfasst von J Brett Heimlich und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (J.B.H., J.W., S.O., M.T., K.F., E.B., K.U., Y.R.S., D.M.R., C.M.B., A.G.B.). Hauptthemen laut MEDLINE: Coronary Artery Disease, Clonal Hematopoiesis, Mutation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP) occurs due to acquired mutations in bone marrow progenitor cells. CHIP confers a 2-fold risk of atherosclerotic cardiovascular disease. However, there are limited data regarding specific cardiovascular phenotypes. The purpose of this study was to define the coronary artery disease phenotype of the CHIP population-based on coronary angiography. METHODS: We recruited 1142 patients from the Vanderbilt University Medical Center cardiac catheterization laboratory and performed DNA sequencing to determine CHIP status. Multivariable logistic regression models and proportional odds models were used to assess the association between CHIP status and angiography phenotypes. RESULTS: We found that 18.4% of patients undergoing coronary angiography had a CHIP mutation. Those with CHIP had a higher risk of having obstructive left main (odds ratio, 2.44 [95% CI, 1.40–4.27]; P =0.0018) and left anterior descending (odds ratio, 1.59 [1.12–2.24]; P =0.0092) coronary artery disease compared with non-CHIP carriers. We additionally found that a specific CHIP mutation, ten eleven translocase 2 (TET2 ), has a larger effect size on left main stenosis compared with other CHIP mutations. CONCLUSIONS: This is the first invasive assessment of coronary artery disease in CHIP and offers a description of a specific atherosclerotic phenotype in CHIP wherein there is an increased risk of obstructive left main and left anterior descending artery stenosis, especially among TET2 mutation carriers. This serves as a basis for understanding enhanced morbidity and mortality in CHIP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine (J.B.H., J.W., S.O., M.T., K.F., E.B., K.U., Y.R.S., D.M.R., C.M.B., A.G.B.).
- Division of Cardiology, Department of Medicine, University of California, Los Angeles (M.A.R.).
- Department of Medicine, Queen's University, Kingston, ON, Canada (C.V.).
- Department of Pharmacology (D.M.R.).
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN (D.M.R.).
ORCID-Profile: J Brett Heimlich, Michael A Raddatz, John Wells, Caitlyn Vlasschaert, Marcus Threadcraft, Kelsey Umbarger, Yan Ru Su, Colin M Barker, Alexander G Bick
Förderung
- NIH HHS
- NIA NIH HHS
Zitieren
APA
Heimlich, J. B., Raddatz, M. A., Wells, J., Vlasschaert, C., Olson, S., Threadcraft, M., Foster, K., Boateng, E., Umbarger, K., Su, Y. R., Roden, D. M., Barker, C. M., & Bick, A. G. (2024). Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate Potential. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.123.004415
Vancouver
Heimlich JB, Raddatz MA, Wells J, Vlasschaert C, Olson S, Threadcraft M, et al. Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate Potential. Circulation: Genomic and Precision Medicine. 2024. doi:10.1161/circgen.123.004415
BibTeX
@article{Heimlich2024,
author = {Heimlich, J Brett and Raddatz, Michael A and Wells, John and Vlasschaert, Caitlyn and Olson, Sydney and Threadcraft, Marcus and Foster, Kristoff and Boateng, Emmanuel and Umbarger, Kelsey and Su, Yan Ru and Roden, Dan M and Barker, Colin M and Bick, Alexander G},
title = {Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate Potential},
journal = {Circulation: Genomic and Precision Medicine},
year = {2024},
doi = {10.1161/circgen.123.004415}
}
EUVIMED